vs
百利高（PRGO）与Voya Financial, Inc.（VOYA）财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是Voya Financial, Inc.的1.8倍（$1.1B vs $603.0M），Voya Financial, Inc.净利率更高（23.2% vs -127.8%，领先151.0%），Voya Financial, Inc.同比增速更快（7.5% vs -2.5%），过去两年Voya Financial, Inc.的营收复合增速更高（7.8% vs 1.3%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
Voya Financial是总部位于美国纽约的金融服务机构，业务覆盖退休规划、投资管理及保险领域。其前身为ING集团美国运营子公司，2013年完成分拆并通过首次公开募股获得独立资金支持，2014年4月正式启用Voya Financial品牌，旗下前身机构最早在1970年代就已进入美国市场。
PRGO vs VOYA — 直观对比
营收规模更大
PRGO
是对方的1.8倍
$603.0M
营收增速更快
VOYA
高出10.0%
-2.5%
净利率更高
VOYA
高出151.0%
-127.8%
两年增速更快
VOYA
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $603.0M |
| 净利润 | $-1.4B | $140.0M |
| 毛利率 | 32.6% | — |
| 营业利润率 | -116.0% | 28.0% |
| 净利率 | -127.8% | 23.2% |
| 营收同比 | -2.5% | 7.5% |
| 净利润同比 | -3093.9% | 44.3% |
| 每股收益（稀释后） | $-10.23 | $1.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGOVOYA
| Q4 25 | $1.1B | $603.0M | ||
| Q3 25 | $1.0B | $572.0M | ||
| Q2 25 | $1.1B | $542.0M | ||
| Q1 25 | $1.0B | $538.0M | ||
| Q4 24 | $1.1B | $561.0M | ||
| Q3 24 | $1.1B | $542.0M | ||
| Q2 24 | $1.1B | $528.0M | ||
| Q1 24 | $1.1B | $519.0M |
净利润PRGOVOYA
| Q4 25 | $-1.4B | $140.0M | ||
| Q3 25 | $7.5M | $192.0M | ||
| Q2 25 | $-8.4M | $166.0M | ||
| Q1 25 | $-6.4M | $156.0M | ||
| Q4 24 | $-44.4M | $97.0M | ||
| Q3 24 | $-21.0M | $114.0M | ||
| Q2 24 | $-108.4M | $205.0M | ||
| Q1 24 | $2.0M | $251.0M |
毛利率PRGOVOYA
| Q4 25 | 32.6% | — | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | 33.1% | — |
营业利润率PRGOVOYA
| Q4 25 | -116.0% | 28.0% | ||
| Q3 25 | 7.0% | 53.7% | ||
| Q2 25 | 4.3% | 34.7% | ||
| Q1 25 | 4.5% | 32.2% | ||
| Q4 24 | 10.0% | 21.4% | ||
| Q3 24 | 7.4% | 21.4% | ||
| Q2 24 | -2.5% | 52.3% | ||
| Q1 24 | -5.1% | 55.3% |
净利率PRGOVOYA
| Q4 25 | -127.8% | 23.2% | ||
| Q3 25 | 0.7% | 33.6% | ||
| Q2 25 | -0.8% | 30.6% | ||
| Q1 25 | -0.6% | 29.0% | ||
| Q4 24 | -3.9% | 17.3% | ||
| Q3 24 | -1.9% | 21.0% | ||
| Q2 24 | -10.2% | 38.8% | ||
| Q1 24 | 0.2% | 48.4% |
每股收益（稀释后）PRGOVOYA
| Q4 25 | $-10.23 | $1.41 | ||
| Q3 25 | $0.05 | $1.80 | ||
| Q2 25 | $-0.06 | $1.66 | ||
| Q1 25 | $-0.05 | $1.42 | ||
| Q4 24 | $-0.32 | $0.99 | ||
| Q3 24 | $-0.15 | $0.98 | ||
| Q2 24 | $-0.79 | $1.96 | ||
| Q1 24 | $0.01 | $2.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $2.1B |
| 股东权益账面价值 | $2.9B | $5.0B |
| 总资产 | $8.5B | $178.9B |
| 负债/权益比越低杠杆越低 | — | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资PRGOVOYA
| Q4 25 | — | — | ||
| Q3 25 | $432.1M | — | ||
| Q2 25 | $454.2M | — | ||
| Q1 25 | $409.9M | — | ||
| Q4 24 | $558.8M | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $542.8M | — | ||
| Q1 24 | $658.5M | — |
总债务PRGOVOYA
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B |
股东权益PRGOVOYA
| Q4 25 | $2.9B | $5.0B | ||
| Q3 25 | $4.4B | $5.0B | ||
| Q2 25 | $4.5B | $4.6B | ||
| Q1 25 | $4.4B | $4.4B | ||
| Q4 24 | $4.3B | $4.0B | ||
| Q3 24 | $4.6B | $4.7B | ||
| Q2 24 | $4.5B | $4.0B | ||
| Q1 24 | $4.7B | $4.2B |
总资产PRGOVOYA
| Q4 25 | $8.5B | $178.9B | ||
| Q3 25 | $10.1B | $177.4B | ||
| Q2 25 | $10.1B | $172.4B | ||
| Q1 25 | $9.8B | $163.9B | ||
| Q4 24 | $9.6B | $163.9B | ||
| Q3 24 | $11.2B | $166.9B | ||
| Q2 24 | $10.4B | $161.3B | ||
| Q1 24 | $10.6B | $161.6B |
负债/权益比PRGOVOYA
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.52× | ||
| Q1 24 | — | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | $557.0M |
| 自由现金流经营现金流 - 资本支出 | $148.6M | — |
| 自由现金流率自由现金流/营收 | 13.4% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | — | 3.98× |
| 过去12个月自由现金流最近4个季度 | $145.1M | — |
8季度趋势，按日历期对齐
经营现金流PRGOVOYA
| Q4 25 | $175.4M | $557.0M | ||
| Q3 25 | $51.7M | $168.0M | ||
| Q2 25 | $75.9M | $742.0M | ||
| Q1 25 | $-64.5M | $-179.0M | ||
| Q4 24 | $312.6M | $79.0M | ||
| Q3 24 | $42.2M | $719.0M | ||
| Q2 24 | $9.5M | $316.0M | ||
| Q1 24 | $-1.4M | $231.0M |
自由现金流PRGOVOYA
| Q4 25 | $148.6M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $274.9M | — | ||
| Q3 24 | $15.1M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-26.5M | — |
自由现金流率PRGOVOYA
| Q4 25 | 13.4% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -2.4% | — |
资本支出强度PRGOVOYA
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.3% | — |
现金转化率PRGOVOYA
| Q4 25 | — | 3.98× | ||
| Q3 25 | 6.89× | 0.88× | ||
| Q2 25 | — | 4.47× | ||
| Q1 25 | — | -1.15× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | — | 6.31× | ||
| Q2 24 | — | 1.54× | ||
| Q1 24 | -0.70× | 0.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
VOYA
| Other | $295.0M | 49% |
| Investment Management Segment | $274.0M | 45% |
| Distribution Fees Member | $34.0M | 6% |
